| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/10/2013 | WO2013066151A1 Improving recognition |
| 05/10/2013 | WO2013065922A1 Pharmaceutical composition including a diphenylpropenone compound as an active ingredient for preventing and treating an inflammatory disorder in the nervous system |
| 05/10/2013 | WO2013065224A1 Non-alcoholic beverage containing eudesmol |
| 05/10/2013 | WO2013064883A1 Heteroaryl compounds as sodium channel blockers |
| 05/10/2013 | WO2013064579A1 Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors |
| 05/10/2013 | WO2013064445A1 Imidazopyridazine compounds |
| 05/10/2013 | WO2013064031A1 N-benzylaniline derivative and uses thereof |
| 05/10/2013 | WO2013064029A1 Benzoylurea derivative with anticancer activity and preparation method and use thereof |
| 05/10/2013 | WO2013040471A3 Noribogaine salt ansolvates |
| 05/10/2013 | WO2012178022A3 Therapeutic applications targeting sarm1 |
| 05/10/2013 | WO2012178015A3 Lrrk2 inhibitors |
| 05/10/2013 | WO2012167133A3 Inhibitors of anandamide transport and their therapeutic uses |
| 05/10/2013 | WO2012156317A3 Intranasal pharmaceutical dosage forms comprising naloxone |
| 05/10/2013 | WO2012124311A8 Novel phenylpyridine derivative and drug containing same |
| 05/10/2013 | WO2012117334A8 Mglur5 positive allosteric modulators for use in the treatment of phelan-mcdermid syndrome |
| 05/10/2013 | WO2012019435A3 Composition for treating neurodegenerative disease or neuropathological condition |
| 05/10/2013 | CA2854612A1 Delivery systems for improving oral bioavailability of fenobam, its hydrates, and salts |
| 05/10/2013 | CA2854578A1 Midbrain dopamine (da) neurons for engraftment |
| 05/10/2013 | CA2854462A1 Pak inhibitors for the treatment of fragile x syndrome |
| 05/10/2013 | CA2854225A1 Co-activation of mtor and stat3 pathways to promote neuronal survival and regeneration |
| 05/10/2013 | CA2853971A1 Improving recognition |
| 05/10/2013 | CA2853961A1 Compositions and methods for reduction of amyloid-beta load |
| 05/10/2013 | CA2853931A1 Composition for improving neuropsychological test battery score |
| 05/10/2013 | CA2853926A1 Method for improving executive function |
| 05/10/2013 | CA2853325A1 Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors |
| 05/10/2013 | CA2853282A1 Nicotinic receptor non-competitive modulators |
| 05/10/2013 | CA2849194A1 Imidazopyridazine compounds |
| 05/09/2013 | US20130116312 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging |
| 05/09/2013 | US20130116309 Oligomeric compounds for the modulation of hif-1a expression |
| 05/09/2013 | US20130116279 Bicyclic heteroaryl inhibitors of pde4 |
| 05/09/2013 | US20130116276 New use of neferine |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/09/2013 | US20130115298 Extended release compositions comprising as active compound venlafaxine hydrochloride |
| 05/09/2013 | US20130115224 METHODS OF TREATING DISORDERS USING HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/09/2013 | US20130115221 HIFa prolyl hydroxylation assay |
| 05/08/2013 | EP2589597A2 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (PBR) |
| 05/08/2013 | EP2589390A1 Pharmaceutical composition for treating central and peripheral nervous system diseases of vascular, traumatic, toxic, hypoxic and autoimmune origin |
| 05/08/2013 | EP2589383A1 FKBP subtype-specific rapamycin analogue for use in treatment of diseases |
| 05/08/2013 | EP2589301A1 Ingredient reconstituted from dry fruit and/or carob |
| 05/08/2013 | EP2588480A2 3,4-DIHYDROPYRROLO[1,2-A]PYRAZINE-2,8(1H)-DICARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF& xA; |
| 05/08/2013 | EP2588479A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 05/08/2013 | EP2588466A1 5-amino-3,6-dihydro-1h-pyrazin-2-one derivatives useful as inhibitors of beta-secretase (bace) |
| 05/08/2013 | EP2588198A1 Treatment of cognitive disorders |
| 05/08/2013 | EP2588196A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/08/2013 | EP2588132A2 Methods and compositions for cns delivery of -galactocerebrosidase |
| 05/08/2013 | EP2588131A2 Methods and compositions for cns delivery of heparan n-sulfatase |
| 05/08/2013 | EP2588130A1 Cns delivery of therapeutic agents |
| 05/08/2013 | EP2588123A2 C1orf32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders |
| 05/08/2013 | EP2588122A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 05/08/2013 | EP2588112A2 Methods and compositions for treatment of multiple sclerosis |
| 05/08/2013 | EP2588109A1 Use of kynurenic acid amide derivatives for the treatment of huntington's disease |
| 05/08/2013 | EP2588099A2 Methods of treating restless legs syndrome |
| 05/08/2013 | EP2588094A2 Pharmaceutical compositions for sublingual delivery of opioids |
| 05/08/2013 | EP2587919A1 Methods for treating post traumatic stress disorder |
| 05/08/2013 | DE112011102397T5 Pharmazeutische Kombinationszusammensetzungen und Verfahren zur Behandlung von Schwindel, Kinetose und vegetativ-vaskulärer Dystonie A pharmaceutical combination compositions and methods for treating vertigo, motion sickness and vegetative-vascular dystonia |
| 05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 05/08/2013 | CN103097389A 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
| 05/08/2013 | CN103097381A 1, 8-naphthyridines as kinase inhibitors |
| 05/08/2013 | CN103097380A Inhibitor of casein kinase 1[delta] and casein kinase 1[epsilon] |
| 05/08/2013 | CN103097364A Spiro-Cyclic Amine Derivatives as S1P Modulators |
| 05/08/2013 | CN103097357A Pyrazole compound |
| 05/08/2013 | CN103096879A Enteric Tablet |
| 05/08/2013 | CN103087133A Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 05/08/2013 | CN103087120A Preparation method and application of monosialotetrahexosylganglioside |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087067A Compound serving as dipeptidyl enzyme inhibitor and composition thereof and applications of compound and composition |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103087024A Flavone alkylamine compounds as well as preparation method and application thereof |
| 05/08/2013 | CN103086981A New compounds |
| 05/08/2013 | CN103086980A Pyrimidine compound for efficiently promoting stem cell proliferation and use thereof |
| 05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
| 05/08/2013 | CN103086936A Aryl compounds as PPAR ligands and their use |
| 05/08/2013 | CN103086926A Preparation method for leonurine and derivatives thereof |
| 05/08/2013 | CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use |
| 05/08/2013 | CN103086908A N-benzylaniline derivatives and application thereof |
| 05/08/2013 | CN103086862A Hydroxydecyl quinone derivative for treating or preventing nerve diseases |
| 05/08/2013 | CN103086861A Hydroxydecyl benzoquinone derivative and application thereof |
| 05/08/2013 | CN103083670A Application of inhibiting agent of cathepsin K |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083667A Continuous dosage scheme of olfactory ensheathing cell proliferation reagent |
| 05/08/2013 | CN103083646A Application of poly cytosine binding protein-1 in preparation of medicine for preventing and treating Parkinson disease |
| 05/08/2013 | CN103083645A Application of neuregulin 1 and acceptor thereof as target for preparing and screening anti-epileptic drugs |
| 05/08/2013 | CN103083644A Dimeric iap inhibitors |
| 05/08/2013 | CN103083623A Application of compound traditional Chinese medicine preparation in Parkinson disease treatment drug preparation |
| 05/08/2013 | CN103083615A Chinese medicament for treating neurodermatitis and preparation method thereof |
| 05/08/2013 | CN103083613A Traditional Chinese medicine composition for treating migraine |
| 05/08/2013 | CN103083560A Tall gastrodia tuber and wild jujube seed composite capsules |
| 05/08/2013 | CN103083559A Novel preparation method and application of traditional Chinese medicine composition for treating cerebral infarction during acute stage and earlier restoration stage |
| 05/08/2013 | CN103083558A Novel application of traditional Chinese medicine composition for treating cerebral infarction during acute stage and earlier restoration stage |
| 05/08/2013 | CN103083557A Traditional Chinese medicine composition with functions of reducing blood pressure and blood fat |
| 05/08/2013 | CN103083554A Ginseng rhizoma gastrodiae elatae pill |
| 05/08/2013 | CN103083548A Healthcare foot bath bag and preparation process thereof |
| 05/08/2013 | CN103083545A Application of Huolisu oral liquid synergistic tandospirone or salt thereof in treatment of anxiety |
| 05/08/2013 | CN103083543A Chinese medicinal composition for soothing nerves and nourishing brain and preparation method thereof |
| 05/08/2013 | CN103083530A Tradtional Chinese medicine for treating brachial plexus neuralgia |
| 05/08/2013 | CN103083526A Smoking-cessation granule |
| 05/08/2013 | CN103083517A Traditional Chinese medicine for treating child cerebral palsy |
| 05/08/2013 | CN103083507A Traditional Chinese medicine for treating prosopalgia |
| 05/08/2013 | CN103083505A Liver-soothing and qi-regulating traditional Chinese medicine composition used for treating depression, and preparation method thereof |
| 05/08/2013 | CN103083501A Soft capsule preparation for preventing and treating diseases of old people |